OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
May 30, 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 29, 2024
An ordered process describing calculations activities for compounded dosage forms is described.
Webinar Date/Time: Tue, July 25, 2024 10:00 AM EDT
May 25, 2024
In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
May 24, 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
May 21, 2024
Webinar Date/Time: Mon, Jun 24, 2024 11:00 AM EDT
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.
May 18, 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.